1. Home
  2. MRVI vs PPTA Comparison

MRVI vs PPTA Comparison

Compare MRVI & PPTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • PPTA
  • Stock Information
  • Founded
  • MRVI 2020
  • PPTA 2011
  • Country
  • MRVI United States
  • PPTA United States
  • Employees
  • MRVI N/A
  • PPTA N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • PPTA Precious Metals
  • Sector
  • MRVI Health Care
  • PPTA Basic Materials
  • Exchange
  • MRVI Nasdaq
  • PPTA Nasdaq
  • Market Cap
  • MRVI 809.2M
  • PPTA 854.6M
  • IPO Year
  • MRVI 2020
  • PPTA N/A
  • Fundamental
  • Price
  • MRVI $5.58
  • PPTA $12.74
  • Analyst Decision
  • MRVI Buy
  • PPTA Strong Buy
  • Analyst Count
  • MRVI 11
  • PPTA 2
  • Target Price
  • MRVI $10.03
  • PPTA $18.50
  • AVG Volume (30 Days)
  • MRVI 1.6M
  • PPTA 823.4K
  • Earning Date
  • MRVI 11-07-2024
  • PPTA 11-13-2024
  • Dividend Yield
  • MRVI N/A
  • PPTA N/A
  • EPS Growth
  • MRVI N/A
  • PPTA N/A
  • EPS
  • MRVI N/A
  • PPTA N/A
  • Revenue
  • MRVI $276,920,000.00
  • PPTA N/A
  • Revenue This Year
  • MRVI N/A
  • PPTA N/A
  • Revenue Next Year
  • MRVI $3.41
  • PPTA N/A
  • P/E Ratio
  • MRVI N/A
  • PPTA N/A
  • Revenue Growth
  • MRVI N/A
  • PPTA N/A
  • 52 Week Low
  • MRVI $4.28
  • PPTA $2.69
  • 52 Week High
  • MRVI $11.56
  • PPTA $13.18
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.01
  • PPTA 64.64
  • Support Level
  • MRVI $5.45
  • PPTA $11.26
  • Resistance Level
  • MRVI $6.01
  • PPTA $12.96
  • Average True Range (ATR)
  • MRVI 0.34
  • PPTA 0.82
  • MACD
  • MRVI 0.12
  • PPTA 0.14
  • Stochastic Oscillator
  • MRVI 63.43
  • PPTA 84.93

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About PPTA Perpetua Resources Corp.

Perpetua Resources Corp is focused on the exploration, site restoration, and redevelopment of gold-antimony-silver deposits in the Stibnite-Yellow Pine district of central Idaho that are encompassed by the Stibnite Gold Project. The Project is one of the highest-grade, open-pit gold deposits in the United States and is designed to apply a modern, responsible mining approach to restore an abandoned mine site and produce both gold and the only mined source of antimony in the United States. It has one segment, mineral exploration in the United States.

Share on Social Networks: